Uncovering patterns of cognitive dysfunction in patients with newly diagnosed high-grade gliomas

Specialists have reported new findings from a study documenting cognitive dysfunction, and evaluating the Montreal Cognitive Assessment (MoCA) as a screening tool, in patients with newly diagnosed high-grade (WHO grade III and IV) gliomas.